The Charter of the French Language and its regulations govern the consultation of English-language content.


2601 Chemin de la Canardière
Québec (Québec)
G1J 2G3
Canada
Professeure titulaire, Université Laval
Département de psychiatrie et de neurosciences, Faculté de médecine
Chercheure, Centre de recherche CERVO
Directrice de l’axe Neurosciences cliniques et cognitives, Centre de recherche CERVO
Directrice de la Plateforme de biostatistique en neurosciences
Axe de recherche:
Neurosciences cliniques et cognitives
La recherche de la Dre Mérette est hautement collaborative. Son expertise en biostatistique et son expérience dans plusieurs domaines en santé lui permettent de conceptualiser et d’élaborer des projets en proposant la méthodologie la plus optimale pour répondre à la question de recherche. Les objectifs poursuivis par ses travaux visent principalement à détecter les facteurs de risque de troubles de santé mentale, à en comprendre les mécanismes causals sous-jacents et à valider l’efficacité d’une intervention par essai clinique tel que celui récemment complété dans une population d’enfants atteints d’un handicap physique où l’efficacité d’une approche basée sur le « solution-focused coaching » a été évaluée.
La Dre Mérette a développé une Plateforme de biostatistique dont le but est d’offrir à l’ensemble des chercheurs en psychiatrie et neurosciences une méthodologie de pointe pour valoriser et optimiser leurs données de recherche. L’équipe de biostatisticiens qu’elle dirige accompagne les chercheurs dans l’identification des mesures optimales à leur recherche, dans la conceptualisation de la base de données en exploitant les ressources numériques offertes par VALERIA, dans l’analyse statistique et la publication des résultats. La Plateforme de biostatistique travaille de concert avec la Plateforme PREDIS de IA en santé afin de rallier l’intelligence artificielle aux sciences des données.
Avec ses collaborateurs, la recherche de la Dre Mérette a permis de détecter et de valider des biomarqueurs de risque de maladies neurodéveloppementales, telles que la schizophrénie, la dépression majeure récurrente, et le trouble bipolaire. En particulier, elle a étudié l’électrorétinographie (ERG) chez des enfants à risque de ces maladies psychiatriques sévères et a pu démontrer la valeur prédictive de l’ERG pour dépister une prédisposition à la psychose. Un tel outil de dépistage pourrait aider à intervenir de manière préventive, à valider un diagnostic et ainsi éviter les délais de traitement reliés à la variabilité des premiers symptômes, et à guider la modalité de traitement.
En collaboration avec la chercheure-clinicienne et directrice de la Clinique de psychiatrie périnatale à l’IUSMQ, la Dre Marie-Josée Poulin, nous étudions les trajectoires de soins de plus de 1000 femmes qui ont été suivies à cette clinique depuis son ouverture en 2004. Grâce à l’inspection rigoureuse de leur dossier, nous avons pu décrire le parcours périnatal en terme des antécédents en santé mentale, de la vulnérabilité pendant la grossesse et de l’émergence de nouvelles incidences dans la première année postpartum. L’étude révèle une multitude de trajectoires complexes, impliquant parfois des comorbidités, mais aussi des facteurs qui permettent de prédire l’évolution des symptômes et diagnostics d’une phase périnatale à l’autre.
Grâce à la collaboration avec la chercheure en orthophonie, Dre Audette Sylvestre, nous étudions les trajectoires développementales de la parole et du langage chez les enfants négligés ou à risque de troubles de santé mentale en les comparant à celles des enfants normaux contrôles. Ces trajectoires longitudinales, et leur interrelation avec les interactions mère-enfant et le comportement, sont modélisées avec des équations structurelles (« structural equation modeling ») et des modèles « cross-lagged panel » qui permettent de vérifier la structure des relations dans le temps et de tester les hypothèses de causalité.
Les travaux effectués par la Dre Mérette et son équipe sont au service de la recherche en psychiatrie et neurosciences visant une meilleure compréhension des processus fondamentaux qui sous-tendent le fonctionnement du cerveau, une meilleure connaissance des trajectoires développementales de troubles psychiatriques, une détection précoce des premiers symptômes ainsi que de meilleures interventions en santé mentale.
Charles-Yoland Desfossés; Rossana Peredo; Andréane Chabot; Jean-Philippe Carmel; Pierre-Marc Tremblay; Chantal Mérette; Geneviève Picher; Isabelle Lachance; Simon Patry; Morgane Lemasson
The Pattern of Change in Depressive Symptoms and Inflammatory Markers After Electroconvulsive Therapy: A Systematic Review Article de journal
Dans: J ECT, vol. 37, no 4, p. 291–297, 2021, ISSN: 1533-4112.
@article{pmid34294652,
title = {The Pattern of Change in Depressive Symptoms and Inflammatory Markers After Electroconvulsive Therapy: A Systematic Review},
author = {Charles-Yoland Desfossés and Rossana Peredo and Andréane Chabot and Jean-Philippe Carmel and Pierre-Marc Tremblay and Chantal Mérette and Geneviève Picher and Isabelle Lachance and Simon Patry and Morgane Lemasson},
doi = {10.1097/YCT.0000000000000782},
issn = {1533-4112},
year = {2021},
date = {2021-12-01},
journal = {J ECT},
volume = {37},
number = {4},
pages = {291--297},
abstract = {Depression is a major mental health disorder, and its pathophysiology is still largely unknown, as is the action mechanism of electroconvulsive therapy (ECT). Some evidence suggests that inflammation might play a role in depression, and several studies have attempted to demonstrate a link between ECT and cytokines. This systematic review used a qualitative analysis to assess the effect of ECT on inflammatory markers as it relates to the clinical response of depressive symptoms in major depressive disorders. The bibliographic search engines CINAHL, Embase, PsychInfo, and PubMed were used to identify articles published up to July 2020. Search terms related to depression, ECT, and inflammation were used. Descriptive statistical analyses were performed to relate changes in inflammatory markers to clinical response to ECT. Twenty-five studies were included in the analysis. No systematic increases or decreases were found in a given inflammatory marker over the ECT; however, we observed that tumor necrosis factor α and interleukin-6 (IL-6) were more often found to be decreased after ECT, whereas IL-8 and IL-10 were more often found to be increased after treatment. No trend in correlation was found between the degree of clinical improvement of depressive symptoms and the variation of any inflammatory markers, despite positive clinical response to ECT. Great heterogeneity with regard to methodology used and lack of power of the studies included in this review could explain the lack of systematic change and correlation found in this study. Future research conducted on this subject should take into account these methodological limitations to allow subsequent meta-analysis.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Annie Vallières; Chantal Mérette; Alric Pappathomas; Monica Roy; Célyne H Bastien
Psychosocial Features of Shift Work Disorder Article de journal
Dans: Brain Sci, vol. 11, no 7, 2021, ISSN: 2076-3425.
@article{pmid34356162,
title = {Psychosocial Features of Shift Work Disorder},
author = {Annie Vallières and Chantal Mérette and Alric Pappathomas and Monica Roy and Célyne H Bastien},
doi = {10.3390/brainsci11070928},
issn = {2076-3425},
year = {2021},
date = {2021-07-01},
journal = {Brain Sci},
volume = {11},
number = {7},
abstract = {To better understand Shift Work Disorder (SWD), this study investigates insomnia, sleepiness, and psychosocial features of night workers. The study compares night workers with or without SWD to day workers with or without insomnia. Seventy-nine night workers and 40 day workers underwent diagnostic interviews for sleep disorders and for psychopathologies. They completed questionnaires and a sleep diary for 14 days. The design was observatory upon two factors: Work schedule (night, day work) and sleep (good sleep, SWD/insomnia). Two-way ANCOVAs were conducted on psychosocial variables, and effect size were calculated. The clinical approach chosen led to distinct groups of workers. Night workers slept several periods (main sleep period after work, naps, nights on days off). High total wake time and low total sleep time characterized sleep in SWD. Most night workers with SWD still complained of sleepiness after main sleep. Cognitive activation distinguished groups of night workers. All other differences in psychosocial variables between night workers groups were similar to, but smaller than, the ones between day workers. The evaluation of SWD should consider all sleep periods of night workers with particular attention to self-reported total wake time, state sleepiness, and level of cognitive activation.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Martin D Provencher; Emma Morton; Anne Sophie Beaudoin; Judith Guillemette; Evelyne Rheault; Chantal Mérette; Laurent Coque; Lisa D Hawke; Erin E Michalak
The Quality of Life in Bipolar Disorder (QoL.BD) Scale: Validation of a French Cross-Cultural Adaptation Article de journal
Dans: Can J Psychiatry, vol. 66, no 3, p. 298–305, 2021, ISSN: 1497-0015.
@article{pmid32783472,
title = {The Quality of Life in Bipolar Disorder (QoL.BD) Scale: Validation of a French Cross-Cultural Adaptation},
author = {Martin D Provencher and Emma Morton and Anne Sophie Beaudoin and Judith Guillemette and Evelyne Rheault and Chantal Mérette and Laurent Coque and Lisa D Hawke and Erin E Michalak},
doi = {10.1177/0706743720948663},
issn = {1497-0015},
year = {2021},
date = {2021-03-01},
journal = {Can J Psychiatry},
volume = {66},
number = {3},
pages = {298--305},
abstract = {OBJECTIVE: The goal of this study was to validate the French version of the Quality of Life in Bipolar Disorder (QoL.BD) scale, a condition-specific measure for bipolar disorder (BD).nnMETHOD: The QoL.BD scale was translated into French in accordance with the recommendations for transcultural adaptation. It was administered to 125 participants with BD living in Quebec, Canada. Construct validity was evaluated through correlations with other measures of self-reported quality of life (QoL), functioning, and symptoms. Factorial structure was examined through an exploratory factor analysis.nnRESULTS: Internal reliability and test-retest reliability standards were met. Correlations in expected directions with other QoL, functioning, and depressive symptom scales supported convergent validity. The item loadings structure of the French QoL.BD largely replicated the original English version, with some modifications.nnCONCLUSION: The French version of the QoL.BD (full and brief) is comparable in its psychometric properties to the English version. It is a valid and sound measure for the evaluation of the QoL of French-speaking patients with BD.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Charles M Morin; Denise C Jarrin; Hans Ivers; Chantal Mérette; Mélanie LeBlanc; Josée Savard
Incidence, Persistence, and Remission Rates of Insomnia Over 5 Years Article de journal
Dans: JAMA Netw Open, vol. 3, no 11, p. e2018782, 2020, ISSN: 2574-3805.
@article{pmid33156345,
title = {Incidence, Persistence, and Remission Rates of Insomnia Over 5 Years},
author = {Charles M Morin and Denise C Jarrin and Hans Ivers and Chantal Mérette and Mélanie LeBlanc and Josée Savard},
doi = {10.1001/jamanetworkopen.2020.18782},
issn = {2574-3805},
year = {2020},
date = {2020-11-01},
journal = {JAMA Netw Open},
volume = {3},
number = {11},
pages = {e2018782},
abstract = {IMPORTANCE: Insomnia is a significant public health problem, but there is little information on its natural history.nnOBJECTIVE: To assess the incidence, persistence, and remission rates of insomnia over a 5-year naturalistic follow-up period.nnDESIGN, SETTING, AND PARTICIPANTS: This cohort study included participants with and without sleep problems selected from the adult population in Canada from August 2007 to June 2014. Participants completed an annual survey about their sleep and health status for 5 consecutive years.nnEXPOSURE: Using validated algorithms, participants were classified at each assessment as being good sleepers (n = 1717), having an insomnia disorder (n = 538), or having subsyndromal insomnia (n = 818).nnMAIN OUTCOMES AND MEASURES: Survival analyses were used to derive incidence rates of new insomnia among the subgroup of good sleepers at baseline and persistence and remission rates among those with insomnia at baseline. Sleep trajectories were examined by looking at year-person transitions between each consecutive year summed over the 5-year follow-up period. All inferential analyses were weighted according to normalized sampling weights.nnRESULTS: The sample included 3073 adults (mean [SD] age, 48.1 [15.0] years; range, 18.0-95.0 years; 1910 [62.2%] female). Overall, 13.9% (95% CI, 11.0%-17. 5%) of initial good sleepers developed an insomnia syndrome during the 5-year follow-up period, and incidence rates were higher among women than among men (17.6% [95% CI, 13.6%-22.7%] vs 10.1% [95% CI, 6.6%-15.3%; χ2 = 4.43; P = .03). A total of 37.5% (95% CI, 32.6%-42.5%) of participants with insomnia at baseline reported insomnia persisting at each of the 5 annual follow-up times. For subsyndromal insomnia, rates were 62.5% at 1 year to 26.5% at 5 years. For syndromal insomnia, rates were 86.0% at 1 year to 59.1% at 5 years. Conversely, remission rates among those with subsyndromal insomnia were almost double the rates among those with an insomnia syndrome at 1 year (37.5% [95% CI, 31.7%-44.0%] vs 14.0% [95% CI, 9.3%-20.8%]), 3 years (62.7% [95% CI, 56.7%-68.7%] vs 27.6% [95% CI, 20.9%-35.9%]), and 5 years (73.6% [95% CI, 68.0%-78.9%%] vs 40.9% [95% CI, 32.7%-50.4%]). Yearly trajectories showed that individuals who were good sleepers at baseline were 4.2 (95% CI, 3.51-4.89) times more likely to stay good sleepers in the subsequent year, but once they developed insomnia, they were equally likely to report symptoms (47% probability) than to return to a good sleeper status (53% probability) 1 year later. Similarly, those with an insomnia syndrome at any given assessment were more likely (adjusted odds ratio, 1.60; 95% CI, 1.19-2.60) to remain in that status (persistence) than to improve (remittance) at the next assessment; even among those who improved, the odds of relapse were greater (adjusted odds ratio, 2.04; 95% CI, 1.23-3.37) than those to improve in the following year.nnCONCLUSIONS AND RELEVANCE: The findings suggest that insomnia is often a persistent condition. Considering the long-term adverse outcomes associated with persistent insomnia, these findings may have important implication for the prognosis and management of insomnia.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Rossana Peredo; Anne-Marie Gagné; Elsa Gilbert; Marc Hébert; Michel Maziade; Chantal Mérette
Electroretinography may reveal cognitive impairment among a cohort of subjects at risk of a major psychiatric disorder Article de journal
Dans: Psychiatry Res, vol. 291, p. 113227, 2020, ISSN: 1872-7123.
@article{pmid32593852,
title = {Electroretinography may reveal cognitive impairment among a cohort of subjects at risk of a major psychiatric disorder},
author = {Rossana Peredo and Anne-Marie Gagné and Elsa Gilbert and Marc Hébert and Michel Maziade and Chantal Mérette},
doi = {10.1016/j.psychres.2020.113227},
issn = {1872-7123},
year = {2020},
date = {2020-09-01},
journal = {Psychiatry Res},
volume = {291},
pages = {113227},
abstract = {INTRODUCTION: Almost a third of the offspring of parents diagnosed with schizophrenia or bipolar disorder could develop a mental disorder or related symptoms. The objectives of this study were to test the existence of two distinct subgroups of youth at-risk, according to their retinal response to luminance measured with electroretinography (ERG), and to relate the resulting cluster memberships with the cognitive clusters previously reported.nnMETHODOLOGY: A clustering analysis was performed with ERG measurements in 107 at-risk offspring. Each subgroup was compared to a healthy control group of 203 individuals. The ERG subgroup memberships were then associated with the cognitive clusters.nnRESULTS: A two-cluster solution was obtained: HR-Cluster1 (n=53) showed a control-like ERG profile and HR-Cluster2 (n=54) showed reduced rod amplitudes and prolonged cone latencies of the b-wave. Subjects in the HR-Cluster2 were 2.7 times more likely to belong to the most detrimental cognitive subgroup than subjects in the HR-Cluster1 (49% Vs 18%).nnCONCLUSION: At-risk offspring showed two distinct ERG profiles: a control-like and an altered profile. A higher risk of impaired cognitive function was observed in subjects with the altered ERG profile, suggesting the ERG as a potential biomarker of susceptibility to mental illness among youth at risk.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Charles M Morin; Ellemarije Altena; Hans Ivers; Chantal Mérette; Mélanie LeBlanc; Josée Savard; Pierre Philip
Insomnia, hypnotic use, and road collisions: a population-based, 5-year cohort study Article de journal
Dans: Sleep, vol. 43, no 8, 2020, ISSN: 1550-9109.
@article{pmid32112107,
title = {Insomnia, hypnotic use, and road collisions: a population-based, 5-year cohort study},
author = {Charles M Morin and Ellemarije Altena and Hans Ivers and Chantal Mérette and Mélanie LeBlanc and Josée Savard and Pierre Philip},
doi = {10.1093/sleep/zsaa032},
issn = {1550-9109},
year = {2020},
date = {2020-08-01},
journal = {Sleep},
volume = {43},
number = {8},
abstract = {STUDY OBJECTIVES: The study objectives were to examine accidental risks associated with insomnia or hypnotic medications, and how these risk factors interact with sex and age.nnMETHODS: A population-based sample of 3,413 adults (Mage = 49.0 years old; 61.5% female), with or without insomnia, were surveyed annually for five consecutive years about their sleep patterns, sleep medication usage, and road collisions.nnRESULTS: There was a significant risk of reporting road collisions associated with insomnia (hazard ratio [HR] = 1.20; 95% confidence interval [CI] = 1.00-1.45) and daytime fatigue (HR = 1.21; 95% CI = 1.01-1.47). Insomnia and its daytime consequences were perceived to have played some contributory role in 40% of the reported collisions. Both chronic (HR = 1.50; 95% CI = 1.17-1.91) and regular use of sleep medications (HR = 1.58; 95% CI = 1.16-2.14) were associated with higher accidental risks, as well as being young female with insomnia and reporting excessive daytime sleepiness.nnCONCLUSIONS: Both insomnia and use of sleep medications are associated with significant risks of road collisions, possibly because of or in association with some of their residual daytime consequences (i.e. fatigue and poor concentration). The findings also highlight a new group of at-risk patients, i.e. young women reporting insomnia and excessive daytime sleepiness.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Marc Hébert; Chantal Mérette; Anne-Marie Gagné; Thomas Paccalet; Isabel Moreau; Joëlle Lavoie; Michel Maziade
The Electroretinogram May Differentiate Schizophrenia From Bipolar Disorder Article de journal
Dans: Biol Psychiatry, vol. 87, no 3, p. 263–270, 2020, ISSN: 1873-2402.
@article{pmid31443935,
title = {The Electroretinogram May Differentiate Schizophrenia From Bipolar Disorder},
author = {Marc Hébert and Chantal Mérette and Anne-Marie Gagné and Thomas Paccalet and Isabel Moreau and Joëlle Lavoie and Michel Maziade},
doi = {10.1016/j.biopsych.2019.06.014},
issn = {1873-2402},
year = {2020},
date = {2020-02-01},
journal = {Biol Psychiatry},
volume = {87},
number = {3},
pages = {263--270},
abstract = {BACKGROUND: The retina is recognized as an approachable part of the brain owing to their common embryonic origin. The electroretinogram (ERG) has proved to be a valuable tool to investigate psychiatric disorders. We therefore investigated its accuracy as a tool to differentiate schizophrenia (SZ) from bipolar disorder (BP) even after balancing patients for their main antipsychotic medication.nnMETHODS: ERG cone and rod luminance response functions were recorded in 150 patients with SZ and 151 patients with BP and compared with 200 control subjects. We created a subgroup of subjects-45 with SZ and 45 with BP-balanced for their main antipsychotic medication.nnRESULTS: A reduced cone a-wave amplitude and a prolonged b-wave latency were observed in both disorders, whereas a reduced cone b-wave amplitude was present in SZ only. Reduced mixed rod-cone a- and b-wave amplitudes were observed in both disorders. Patients with SZ were distinguishable from control subjects with 0.91 accuracy, 77% sensitivity, and 91% specificity with similar numbers for patients with BP (0.89, 76%, and 88%, respectively). Patients with SZ and patients with BP could be differentiated with an accuracy of 0.86 (whole sample) and 0.83 (subsamples of 45 patients with 80% sensitivity and 82% specificity). Antipsychotic dosages were not correlated with ERG parameters.nnCONCLUSIONS: The ERG waveform parameters used in this study provided a very accurate distinction between the two disorders when using a logistic regression model. This supports the ERG as a tool that could aid the clinician in the differential diagnosis of SZ and BP in stabilized medicated patients.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Sébastien Boies; Chantal Mérette; Thomas Paccalet; Michel Maziade; Alexandre Bureau
Polygenic risk scores distinguish patients from non-affected adult relatives and from normal controls in schizophrenia and bipolar disorder multi-affected kindreds Article de journal
Dans: Am J Med Genet B Neuropsychiatr Genet, vol. 177, no 3, p. 329–336, 2018, ISSN: 1552-485X.
@article{pmid29193655,
title = {Polygenic risk scores distinguish patients from non-affected adult relatives and from normal controls in schizophrenia and bipolar disorder multi-affected kindreds},
author = {Sébastien Boies and Chantal Mérette and Thomas Paccalet and Michel Maziade and Alexandre Bureau},
doi = {10.1002/ajmg.b.32614},
issn = {1552-485X},
year = {2018},
date = {2018-04-01},
journal = {Am J Med Genet B Neuropsychiatr Genet},
volume = {177},
number = {3},
pages = {329--336},
abstract = {Recent studies have used results on SNP association with schizophrenia (SZ) and bipolar disorder (BD) to create polygenic risk scores (PRS) discriminating non-familial unrelated patients from controls. Little is known about the role of PRS in densely affected multigenerational families. We tested PRS differences between affected SZ and BD family members from their non-affected adult relatives (NAARs) in Eastern Quebec Kindreds and from controls. We examined 1227 subjects: from 17 SZ and BD kindreds, we studied 153 patients (57 SZ, 13 schizoaffective, and 83 BD) and 180 NAARs, and 894 unrelated controls from the Eastern Quebec population. PRS were derived from published case-control association studies of SZ and BD. We also constructed a combined SZ and BD PRS by using SNPs from both SZ and BD PRS. SZ patients had higher SZ PRS than controls (p = 0.0039, R = 0.027) and BD patients had higher BD PRS than controls (p = 0.013, R = 0.027). Differences between affected subjects and NAARs and controls were significant with both SZ and BD PRS. Moreover, a combined SZ-BD PRS was also significantly associated with SZ and BD when compared to NAARs (p = 0.0019, R = 0.010) and controls (p = 0.0025, R = 0.028), revealing a SZ-BD commonality effect in PRS at the diagnosis level. The SZ and the BD PRS, however, showed a degree of specificity regarding thought disorder symptoms. Overall, our report would confirm the usefulness of PRS in capturing the contribution of common genetic variants to the risk of SZ and BD in densely affected families.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Marc Hébert; Chantal Mérette; Thomas Paccalet; Anne-Marie Gagné; Michel Maziade
Electroretinographic anomalies in medicated and drug free patients with major depression: Tagging the developmental roots of major psychiatric disorders Article de journal
Dans: Prog Neuropsychopharmacol Biol Psychiatry, vol. 75, p. 10–15, 2017, ISSN: 1878-4216.
@article{pmid28007463,
title = {Electroretinographic anomalies in medicated and drug free patients with major depression: Tagging the developmental roots of major psychiatric disorders},
author = {Marc Hébert and Chantal Mérette and Thomas Paccalet and Anne-Marie Gagné and Michel Maziade},
doi = {10.1016/j.pnpbp.2016.12.002},
issn = {1878-4216},
year = {2017},
date = {2017-04-01},
journal = {Prog Neuropsychopharmacol Biol Psychiatry},
volume = {75},
pages = {10--15},
abstract = {The retina is tagged as an approachable part of the brain due to its common embryonic origin and appears as a promising site of investigation for psychiatric disorders. Retinal function is assessed best with the electroretinogram (ERG), which was obtained in a large sample of patients with major depressive disorder and matched controls. ERG cone and rod luminance response functions were recorded in non-dilated eyes in 100 major depressive disorder patients (MDD) and 100 controls, (mean age of 42.8 and 40.9y. o. respectively). Amongst MDD patients, 17 were drug free (mean age 41.2y. o). In medicated patients, at the cone level, a prolonged b-wave was observed (p≤0.01). In drug free patients a prolonged b-wave was discovered only when averaging the implicit time of the 3 highest b-wave amplitudes of the photopic hill. For the medicated patients, the mixed rods/cones a-wave was reduced (p=0.01) whereas a trend (p=0.06) was observed for the pure rod b-wave (reduced) and the mixed rods/cones (reduced and prolonged; p=0.05). In drug free patients, a similar pattern could be observed in terms of effect sizes. Overall, medicated and drug free MDD patients shared some deficits suggesting that some anomalies are present above and beyond the effect of medication. Of interest, the prolonged cone and reduced rod amplitude were reported by our group in schizophrenia patients, suggesting a common neurodevelopmental root of major psychiatric disorders.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Denise C Jarrin; Charles M Morin; Amélie Rochefort; Hans Ivers; Yves A Dauvilliers; Josée Savard; Mélanie LeBlanc; Chantal Merette
Familial Aggregation of Insomnia Article de journal
Dans: Sleep, vol. 40, no 2, 2017, ISSN: 1550-9109.
@article{pmid28364499,
title = {Familial Aggregation of Insomnia},
author = {Denise C Jarrin and Charles M Morin and Amélie Rochefort and Hans Ivers and Yves A Dauvilliers and Josée Savard and Mélanie LeBlanc and Chantal Merette},
doi = {10.1093/sleep/zsw053},
issn = {1550-9109},
year = {2017},
date = {2017-02-01},
journal = {Sleep},
volume = {40},
number = {2},
abstract = {STUDY OBJECTIVES: There is little information about familial aggregation of insomnia; however, this type of information is important to (1) improve our understanding of insomnia risk factors and (2) to design more effective treatment and prevention programs. This study aimed to investigate evidence of familial aggregation of insomnia among first-degree relatives of probands with and without insomnia.nnMETHODS: Cases (n = 134) and controls (n = 145) enrolled in a larger epidemiological study were solicited to invite their first-degree relatives and spouses to complete a standardized sleep/insomnia survey. In total, 371 first-degree relatives (Mage = 51.9 years, SD = 18.0; 34.3% male) and 138 spouses (Mage = 55.5 years, SD = 12.2; 68.1% male) completed the survey assessing the nature, severity, and frequency of sleep disturbances. The dependent variable was insomnia in first-degree relatives and spouses. Familial aggregation was claimed if the risk of insomnia was significantly higher in the exposed (relatives of cases) compared to the unexposed cohort (relatives of controls). The risk of insomnia was also compared between spouses in the exposed (spouses of cases) and unexposed cohort (spouses of controls).nnRESULTS: The risk of insomnia in exposed and unexposed biological relatives was 18.6% and 10.4%, respectively, yielding a relative risk (RR) of 1.80 (p = .04) after controlling for age and sex. The risk of insomnia in exposed and unexposed spouses was 9.1% and 4.2%, respectively; however, corresponding RR of 2.13 (p = .28) did not differ significantly.nnCONCLUSIONS: Results demonstrate evidence of strong familial aggregation of insomnia. Additional research is warranted to further clarify and disentangle the relative contribution of genetic and environmental factors in insomnia.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}

